Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Changes in intraocular pressure after intraocular eye surgery-the influence of measuring technique.

Kovacic H, Wolfs RCW, Kılıç E, Ramdas WD.

Int J Ophthalmol. 2019 Jun 18;12(6):967-973. doi: 10.18240/ijo.2019.06.14. eCollection 2019.

2.

Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis.

Smit KN, Chang J, Derks K, Vaarwater J, Brands T, Verdijk RM, Wiemer EAC, Mensink HW, Pothof J, de Klein A, Kilic E.

Cancers (Basel). 2019 Jun 12;11(6). pii: E815. doi: 10.3390/cancers11060815.

3.

Stem cells combined 3D electrospun nanofibrous and macrochannelled matrices: a preliminary approach in repair of rat cranial bones.

İşoğlu İA, Bölgen N, Korkusuz P, Vargel İ, Çelik HH, Kılıç E, Güzel E, Çavuşoğlu T, Uçkan D, Pişkin E.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1094-1100. doi: 10.1080/21691401.2019.1593850.

PMID:
30942631
4.

Absence of Intraocular Lymphatic Vessels in Uveal Melanomas with Extrascleral Growth.

van Beek JGM, van den Bosch QCC, Naus N, Paridaens D, de Klein A, Kiliç E, Verdijk RM.

Cancers (Basel). 2019 Feb 15;11(2). pii: E228. doi: 10.3390/cancers11020228.

5.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1328-1341. doi: 10.1093/jnci/djy171.

PMID:
30517737
6.

Reply.

van Poppelen NM, Vaarwater J, Mudhar HS, Sisley K, van den Bosch QCC, de Klein A, Kiliç E, Verdijk RM.

Ophthalmology. 2018 Nov;125(11):e79-e80. doi: 10.1016/j.ophtha.2018.05.022. No abstract available.

PMID:
30318045
7.

Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.

van Beek JGM, Buitendijk GHS, Timman R, Muller K, Luyten GPM, Paridaens D, Naus NC, Kiliç E.

Acta Ophthalmol. 2018 Dec;96(8):841-848. doi: 10.1111/aos.13823. Epub 2018 Oct 3.

PMID:
30284368
8.

Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.

Szalai E, Jiang Y, van Poppelen NM, Jager MJ, de Klein A, Kilic E, Grossniklaus HE.

JAMA Ophthalmol. 2018 Oct 1;136(10):1115-1120. doi: 10.1001/jamaophthalmol.2018.2986.

PMID:
30073324
9.

Chromosomal rearrangements in uveal melanoma: Chromothripsis.

van Poppelen NM, Yavuzyigitoglu S, Smit KN, Vaarwater J, Eussen B, Brands T, Paridaens D, Kiliç E, de Klein A.

Genes Chromosomes Cancer. 2018 Sep;57(9):452-458. doi: 10.1002/gcc.4. Epub 2018 Jul 30.

10.

Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.

van Poppelen NM, Vaarwater J, Mudhar HS, Sisley K, Rennie IG, Rundle P, Brands T, van den Bosch QCC, Mensink HW, de Klein A, Kiliç E, Verdijk RM.

Ophthalmology. 2018 Jun;125(6):904-912. doi: 10.1016/j.ophtha.2017.12.022. Epub 2018 Jan 19.

11.

Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.

Smit KN, van Poppelen NM, Vaarwater J, Verdijk R, van Marion R, Kalirai H, Coupland SE, Thornton S, Farquhar N, Dubbink HJ, Paridaens D, de Klein A, Kiliç E.

Mod Pathol. 2018 May;31(5):763-771. doi: 10.1038/modpathol.2017.187. Epub 2018 Jan 12.

12.

Intra-ocular diathermy forceps.

van Overdam KA, Kilic E, Verdijk RM, Manning S.

Acta Ophthalmol. 2018 Jun;96(4):420-422. doi: 10.1111/aos.13619. Epub 2017 Dec 2.

13.

Additive effect of mesenchymal stem cells and defibrotide in an arterial rat thrombosis model.

Dilli D, Kılıç E, Yumuşak N, Beken S, Uçkan Çetinkaya D, Karabulut R, Zenciroğlu AL.

Arch Argent Pediatr. 2017 Jun 1;115(3):249-256. doi: 10.5546/aap.2017.eng.249. English, Spanish.

14.

Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.

Yavuzyigitoglu S, Drabarek W, Smit KN, van Poppelen N, Koopmans AE, Vaarwater J, Brands T, Eussen B, Dubbink HJ, van Riet J, van de Werken HJ, Beverloo B, Verdijk RM, Naus N, Paridaens D, Kilic E, de Klein A; Rotterdam Ocular Melanoma Study Group.

Ophthalmology. 2017 Apr;124(4):573-575. doi: 10.1016/j.ophtha.2016.10.039. Epub 2016 Dec 1. No abstract available.

PMID:
27916271
15.

Early surgical treatment of retinal hemangioblastomas.

van Overdam KA, Missotten T, Kilic E, Spielberg LH.

Acta Ophthalmol. 2017 Feb;95(1):97-102. doi: 10.1111/aos.13223. Epub 2016 Sep 29.

16.

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.

Bol KF, van den Bosch T, Schreibelt G, Mensink HW, Keunen JE, Kiliç E, Japing WJ, Geul KW, Westdorp H, Boudewijns S, Croockewit SA, van Rossum MM, de Goede AL, Naus NC, van der Graaf WT, Gerritsen WR, de Klein A, Punt CJ, Figdor CG, Cohen VM, Paridaens D, de Vries IJ.

Ophthalmology. 2016 Oct;123(10):2265-7. doi: 10.1016/j.ophtha.2016.06.027. Epub 2016 Jul 29. No abstract available.

PMID:
27476772
17.

Lipomatous Change in Uveal Melanoma: Histopathological, Immunohistochemical and Cytogenetic Analysis.

Yavuzyigitoglu S, Kilic E, Vaarwater J, de Klein A, Paridaens D, Verdijk RM; Rotterdam Ocular Melanoma Study Group (ROMS).

Ocul Oncol Pathol. 2016 Apr;2(3):133-5. doi: 10.1159/000440981. Epub 2015 Nov 20.

18.

Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.

Yavuzyigitoglu S, Mensink HW, Smit KN, Vaarwater J, Verdijk RM, Beverloo B, Brüggenwirth HT, van Marion R, Dubbink HJ, Paridaens D, Naus NC, de Klein A, Kiliç E; Rotterdam Ocular Melanoma Study Group (ROMS).

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2232-9. doi: 10.1167/iovs.15-18608.

PMID:
27116551
19.

Lactobacillus rhamnosus could inhibit Porphyromonas gingivalis derived CXCL8 attenuation.

Mendi A, Köse S, Uçkan D, Akca G, Yilmaz D, Aral L, Gültekin SE, Eroğlu T, Kiliç E, Uçkan S.

J Appl Oral Sci. 2016 Jan-Feb;24(1):67-75. doi: 10.1590/1678-775720150145.

20.

Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.

Yavuzyigitoglu S, Koopmans AE, Verdijk RM, Vaarwater J, Eussen B, van Bodegom A, Paridaens D, Kiliç E, de Klein A; Rotterdam Ocular Melanoma Study Group.

Ophthalmology. 2016 May;123(5):1118-28. doi: 10.1016/j.ophtha.2016.01.023. Epub 2016 Feb 26.

PMID:
26923342

Supplemental Content

Loading ...
Support Center